Trial intelligence / Profile preview

Intraoperative hyperthermic cisplatin chemotherapy in locally advanced non-small cell lung cancer

2007-005980-83Phase 3Terminated

Sponsor
Centro di Riferimento Oncologico di Aviano
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Overall survival. Started Aug 2008; status: terminated.

02

Drugs

cisplatin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on 2007-005980-83.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005980-83.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call